Showing results (81-90 of 776) with videos related to

Sort By:
Pageof 78
Best Practice & Research. Clinical Haematology|July 20, 2005
Novel biological therapies for the treatment of multiple myelomaPaul G Richardson, Constantine S Mitsiades, Teru Hideshima, et al.
Blood|April 20, 2004
Advances in biology of multiple myeloma: clinical applicationsTeru Hideshima, P Leif Bergsagel, W Michael Kuehl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Proteasome inhibition as a novel therapeutic target in human cancerS Vincent Rajkumar, Paul G Richardson, Teru Hideshima, et al.
Hematology. American Society of Hematology. Education Program|November 21, 2007
The treatment of relapsed and refractory multiple myelomaPaul Richardson, Constantine Mitsiades, Robert Schlossman, et al.
Molecular Cancer Therapeutics|October 14, 2003
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myelomaMasood A Shammas, Robert J Shmookler Reis, Masaharu Akiyama, et al.
Nature Reviews. Cancer|July 25, 2007
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targetsTeru Hideshima, Constantine Mitsiades, Giovanni Tonon, et al.
Expert Review of Anticancer Therapy|April 13, 2007
Targeting the vascular endothelial growth factor pathway in the treatment of multiple myelomaKlaus Podar, Paul G Richardson, Dharminder Chauhan, et al.
Blood|September 27, 2003
Immunomodulatory drug costimulates T cells via the B7-CD28 pathwayRichard LeBlanc, Teru Hideshima, Laurence P Catley, et al.
Blood|March 10, 2009
Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implicationsTeru Hideshima, Dharminder Chauhan, Tanyel Kiziltepe, et al.
Pageof 78